ATNM vs J · rev $35.0M vs P/E 36, rev $4.08B
Actinium Pharmaceuticals Inc (ATNM) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
ATNM currently screens at market cap $33.9M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ATNM and J stock pages for the full models.
Not investment advice.